Thorsten Althoff

Dr. Thorsten Althoff

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2014 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
AGApril Goehring
April Goehring
CLChia-Hsueh Lee
Chia-Hsueh Lee
KWKevin H Wang
Kevin H Wang
JMJennifer Carlisle Michel
Jennifer Carlisle Michel
DCDerek P Claxton
Derek P Claxton
EGEric Gouaux
Eric Gouaux

9 September 2011 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TAThorsten Althoff
Thorsten Althoff
DMDeryck J Mills
Deryck J Mills
JPJean‐Luc Popot
Jean‐Luc Popot
WKWerner Kühlbrandt
Werner Kühlbrandt
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

20 August 2014 in Nature
Verified
Journal Article
Closed access
PDF file
TAThorsten Althoff
Thorsten Althoff
RHRyan E. Hibbs
Ryan E. Hibbs
SBSurajit Banerjee
Surajit Banerjee
EGEric Gouaux
Eric Gouaux

9 June 2011 in Annual Review of Biophysics
Verified
Journal Article
Closed access
JPJ-L Popot
J-L Popot
TAThorsten Althoff
Thorsten Althoff
Dominique BagnardDominique Bagnard
Dominique Bagnard
JBJean-Louis Baneres
Jean-Louis Baneres
PBP Bazzacco
P Bazzacco
MZM Zoonens
M Zoonens
Amphipols (APols) are short amphipathic polymers that can substitute for detergents to keep integral membrane proteins (MPs) water soluble. In this review, we discuss their structure and solution behavior; the way they associate with MPs; and the structure, dynamics, and solution properties of the resulting complexes. All MPs tested to date form water-soluble complexes with APols, and their biochemical stability is in general greatly improved compared with MPs in detergent solutions. The functionality and ligand-binding properties of APol-trapped MPs are reviewed, and the mechanisms by which APols stabilize MPs are discussed. Applications of APols include MP folding and cell-free synthesis, structural studies by NMR, electron microscopy and X-ray diffraction, APol-mediated immobilization of MPs onto solid supports, proteomics, delivery of MPs to preexisting membranes, and vaccine formulation.

7 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
PBPaola Bisignano
Paola Bisignano
CGChiara Ghezzi
Chiara Ghezzi
HJHyunil Jo
Hyunil Jo
NPNicholas F. Polizzi
Nicholas F. Polizzi
TAThorsten Althoff
Thorsten Althoff
MGMichael Grabe
Michael Grabe
Sodium-dependent glucose transporters (SGLTs) exploit sodium gradients to transport sugars across the plasma membrane. Due to their role in renal sugar reabsorption, SGLTs are targets for the treatment of type 2 diabetes. Current therapeutics are phlorizin derivatives that contain a sugar moiety bound to an aromatic aglycon tail. Here, we develop structural models of human SGLT1/2 in complex with inhibitors by combining computational and functional studies. Inhibitors bind with the sugar moiety in the sugar pocket and the aglycon tail in the extracellular vestibule. The binding poses corroborate mutagenesis studies and suggest a partial closure of the outer gate upon binding. The models also reveal a putative Na+ binding site in hSGLT1 whose disruption reduces the transport stoichiometry to the value observed in hSGLT2 and increases inhibition by aglycon tails. Our work demonstrates that subtype selectivity arises from Na+-regulated outer gate closure and a variable region in extracellular loop EL5.

19 May 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MSMichael Shum
Michael Shum
CSChitra A. Shintre
Chitra A. Shintre
TAThorsten Althoff
Thorsten Althoff
VGVincent Gutierrez
Vincent Gutierrez
MSMayuko Segawa
Mayuko Segawa
Marc LiesaMarc Liesa
Marc Liesa
ABCB10 in the liver impairs insulin signaling and promotes hyperglycemia and steatosis.